A systematic review and meta-analysis published in BMC Gastroenterology found that constipation rates with GLP-1 receptor agonists were approximately 2.5 times higher than placebo groups
Conversely, patients taking potassium-sparing diuretics, ACE inhibitors, angiotensin receptor blockers (ARBs), or aldosterone antagonists may be at risk of hyperkalaemia, particularly if renal function declines
When to See a Dermatologist or Hair Clinic Some shedding during GLP-1 treatment can be temporary and expected, especially when weight drops quickly
Clinical trials maintained participants at the full therapeutic dose of 2.4mg weekly
Pre-combining B12 with semaglutide addresses this potential deficiency proactively
Zheng Z., Zong Y., Ma Y., et al., GlucagonLike Peptide1 Receptor: Mechanisms and Advances in Therapy, Signal Transduction and Targeted Therapy 9, no